Trials / Terminated
TerminatedNCT05752123
A Study to Evaluate the Safety and Efficacy of ET-01 Transplantation in Subjects with Transfusion Dependent Β-Thalassaemia.
A Single Site, Open Label Study to Evaluate the Safety and Efficacy of ET-01 Transplantation in Subjects with Transfusion Dependent Β-Thalassemia
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 2 (actual)
- Sponsor
- EdiGene (GuangZhou) Inc. · Industry
- Sex
- All
- Age
- 6 Years – 35 Years
- Healthy volunteers
- Not accepted
Summary
This is an open label, single site study to evaluate the safety and Efficacy of ET-01 Transplantation in subjects with Transfusion Dependent β-Thalassaemia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | ET-01 | Recruited participants will receive ET-01 IV infusion after conditioning. |
Timeline
- Start date
- 2023-02-18
- Primary completion
- 2024-01-29
- Completion
- 2025-03-12
- First posted
- 2023-03-02
- Last updated
- 2025-03-30
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05752123. Inclusion in this directory is not an endorsement.